ENROLLMENT
63%
38 / 60 patients
BUDGET
60%
$1.4M /$ $2.4M
SCREEN FAILURES
17.4%
vs 20.0% benchmark
ACTIVE SITES
2
3.0 total FTE
MILESTONES
3/6
50% complete
ENROLLMENT TRENDS
No projection data available
BUDGET BREAKDOWN
TOTAL BUDGET
$2.40M
CONSUMED
$1.44M
60%
REMAINING
$0.96M
+3% INF$0.99M
Passthrough
$0.96M (40%)
40%
Investigator Fees
$0.60M (25%)
25%
Consumed
$1.44M (60%)
60%
Remaining
$0.96M (40%)
40%
AVG COST PER PATIENT
$40,000
CURRENT BURN RATE
$37,894.737/pt
SITE PERFORMANCE
| SITE | STATUS | ENROLLMENT | TARGET | PROGRESS | SCREEN FAIL | FTE |
|---|---|---|---|---|---|---|
Nashville | 26 | 40 | 65% | 16.1% | 2 | |
Chattanooga | 12 | 20 | 60% | 20.0% | 1 |
RISK REGISTER
MILESTONES
First Patient Enrolled
Target: 9/15/2024 • Completed: 9/12/2024
Cohort 1 Complete (n=12)
Target: 12/1/2024 • Completed: 11/28/2024
Cohort 2 Complete (n=24)
Target: 3/1/2025 • Completed: 2/25/2025
Cohort 3 Complete (n=36)
Target: 6/1/2025
Final Cohort Complete (n=60)
Target: 9/30/2025
Database Lock
Target: 12/31/2025
TRIAL INFORMATION
Protocol Version:1.0
Sponsor:Bridgeway Oncology
Therapeutic Area:Oncology
Start Date:9/1/2024
Est. Completion:12/31/2025
Passthrough:$0.96M
Per Patient:$16,000
Investigator Fees:$10,000/pt